AGAR Group

2019 Meetings

November 2019 Meeting:

AGAR EXECUTIVE AGENDA NOVEMBER 2019 (PDF)
AGAR EXECUTIVE MEETING MINUTES NOVEMBER 2019 (PDF)
AGAR EXECUTIVE MEETING MINUTES JULY 2019 (PDF)
4.1 2018-2019 FINANCIAL ACQUITTAL FOR ASA CONTRACT FOR AGAR(PDF)
4.2 INVOICE FOR DELIVERABLE 2(PDF)
4.3 ACCESS TO AGAR DATA (PDF)
5.0 AGAR OPERATING PROCEDURES 2019 (PDF)
6.0 AGAR 2019 MANAGEMENT PLAN (PDF)
7.1 AGAR SEPTEMBER 2019 FINANCIAL REPORT (PDF)
8.1 2018 BUDGET FINAL (PDF)
8.2 2019 AGAR CONTRACT (PDF)
8.3 2019 AGAR BUDGET (PDF)
10.1 ASSOP 2017 CDI REPORT (PDF)
10.2 AESOP 2017 CDI REPORT (PDF)
10.3 GNSOP 2017 CDI REPORT (PDF)
11.1 ASSOP 2018 (PDF)
11.2 AESOP 2018 (PDF)
11.3 GNSOP 2018 (PDF)
14.3 AURA DATA SUBMISSION TO GLASS (PDF)
14.4 GLASS REQUIREMENTS (PDF)
14.5 WHO PROPOSED AMR INDICATOR – GLASS (PDF)
14.6 FUTURE OF AURA (PDF)
14.7 NEXUS 6 CONTRACT CHANGES FOR NHHI (PDF)
15.1 ASTAG MINUTES – 09072019(PDF)
15.2 CONSULTATION PAPER – AUSTRALIAS NEXT AMR STRATEGY 2020 AND BEYOND (PDF)
15.3 ANTIBIOTIC GUARDIAN (PDF)
16.1 PETER COLLIGNON (PDF)
16.2 JON IREDELL (PDF)
16.3 S. ARGENTEUS (PDF)
17.1 LETTER OF SUPPORT (PDF)
17.2 AGAR PARTICIPATION IN THE NAPS NAUSP DATA STUDY – LOUISE COOLEY (PDF)
17.3. NAPS NAUSP DATA STUDY PROJECT PROTOCOL (PDF)

July 2019 Meeting:

AGAR EXECUTIVE AGENDA JULY 2019 (PDF)
AGAR EXECUTIVE MEETING MINUTES DECEMBER 2018 (PDF)
AGAR EXECUTIVE MEETING MINUTES JULY 2019 (PDF)
4.1 THIRD AUSTRALIAN ATLAS OF HEALTHCARE VARIATION(PDF)
4.2 CDI (PDF)
4.3 2016 AND 2017 CDI REPORT (PDF)
4.4 NSW PATHOLOGY CHILDREN’S HOSPITALS (PDF)
4.5 RESPONSE TO NSW CHILDREN’S HOSPITALS (PDF)
4.6 MRSA A TALE OF THREE TYPES PROPOSED UPDATE (PDF)
4.7 AURA 2019 LAUNCH INVITATION (PDF)
4.8 AURA 2019 LAUNCH PROGRAM (PDF)
5.0 AGAR OPERATING PROCEDURES 2019 (PDF)
6.0 AGAR 2019 MANAGEMENT PLAN (PDF)
7.1 AGAR DECEMBER 2018 FINANCIAL REPORT (PDF)
7.2. AGAR MARCH 2019 FINANCIAL REPORT (PDF)
7.3. AGAR JUNE 2019 FINANCIAL REPORT (PDF)
7.4. AGAR 2018 2019 FINANCIAL REPORT (PDF)
8.1 2018 AGAR FUNDING (PDF)
8.2. 2019 AGAR BUDGET (PDF)
8.3. 2019 AGAR CONTRACT (PDF)
8.4. 2019 AGAR FUNDING (PDF)
8.5. CONTRACT FOR JAN BELL (PDF)
8.6. 2019 AGAR PROJECT PLAN (PDF)
10.1. 2017 AGAR ASSOP CDI Report (PDF)
10.2. 2017 AGAR AESOP CDI Report (PDF)
10.3. 2017 AGAR GNSOP CDI Report (PDF)
11.1. ASSOP 2018 Report (PDF)
11.2. AESOP 2018 Report (PDF)
11.3. GNSOP 2018 Report (PDF)
13.1. AGAR Data Entry Portal Instructions (PDF)
14.1. AURA 2019 Report (PDF)
14.2. 2017 Amalgam Sepsis Outcome Programs Report (PDF)
15.1. Australia’s Next AMR Strategy 2020 and Beyond (PDF)
15.2. Consultation Paper – Australia’s Next AMR Strategy 2020 and Beyond (PDF)
16.1.1.EXACT Protocol Version1.0 (PDF)
16.1.2. Alfred Hospital Ethics Approval (PDF)
17.1. Multiresistance Definitions (PDF)
17.2. GNSOP Data (PDF)
17.3. MRFF Priorites 2018 to 2020 (PDF)

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.